Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

BioCryst Pharmaceuticals Total Assets 2010-2025 | BCRX

BioCryst Pharmaceuticals total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
  
BioCryst Pharmaceuticals Annual Total Assets
(Millions of US $)
2024 $490
2023 $517
2022 $550
2021 $588
2020 $335
2019 $175
2018 $147
2017 $178
2016 $90
2015 $122
2014 $137
2013 $49
2012 $57
2011 $82
2010 $109
2009 $142
BioCryst Pharmaceuticals Quarterly Total Assets
(Millions of US $)
2025-03-31 $480
2024-12-31 $490
2024-09-30 $491
2024-06-30 $472
2024-03-31 $468
2023-12-31 $517
2023-09-30 $523
2023-06-30 $530
2023-03-31 $510
2022-12-31 $550
2022-09-30 $559
2022-06-30 $511
2022-03-31 $528
2021-12-31 $588
2021-09-30 $266
2021-06-30 $277
2021-03-31 $284
2020-12-31 $335
2020-09-30 $176
2020-06-30 $215
2020-03-31 $137
2019-12-31 $175
2019-09-30 $91
2019-06-30 $116
2019-03-31 $142
2018-12-31 $147
2018-09-30 $168
2018-06-30 $137
2018-03-31 $155
2017-12-31 $178
2017-09-30 $191
2017-06-30 $114
2017-03-31 $130
2016-12-31 $90
2016-09-30 $92
2016-06-30 $82
2016-03-31 $103
2015-12-31 $122
2015-09-30 $139
2015-06-30 $150
2015-03-31 $130
2014-12-31 $137
2014-09-30 $137
2014-06-30 $142
2014-03-31 $43
2013-12-31 $49
2013-09-30 $53
2013-06-30 $40
2013-03-31 $47
2012-12-31 $57
2012-09-30 $64
2012-06-30 $76
2012-03-31 $80
2011-12-31 $82
2011-09-30 $93
2011-06-30 $108
2011-03-31 $123
2010-12-31 $109
2010-09-30 $111
2010-06-30 $116
2010-03-31 $125
2009-12-31 $142
2009-09-30 $61
2009-06-30 $65
2009-03-31 $73
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.277B $0.451B
BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential commercialization including Fodosine in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life threatening influenza. BioCryst has a worldwide partnership with Roche for the development and commercialization BCX-4208, and is collaborating with Mundipharma for the development and commercialization of Fodosine in markets across Europe, Asia, Australia and certain neighboring countries.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.912B 32.23
Zoetis (ZTS) United States $74.412B 27.76
Daiichi Sankyo, - (DSNKY) Japan $51.611B 26.26
Takeda Pharmaceutical (TAK) Japan $47.092B 9.37
Sandoz Group AG (SDZNY) Switzerland $21.516B 0.00
Summit Therapeutics (SMMT) United States $19.465B 0.00
Merck (MKKGY) Germany $16.963B 12.43
United Therapeutics (UTHR) United States $14.451B 12.78
Shionogi (SGIOY) Japan $13.900B 13.93
Neurocrine Biosciences (NBIX) United States $12.238B 41.92
IPSEN (IPSEY) France $9.702B 0.00
Orion OYJ (ORINY) Finland $9.462B 25.59
Corcept Therapeutics (CORT) United States $8.233B 66.93
Stevanato Group S.p.A (STVN) Italy $6.929B 42.37
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.993B 0.00
Grifols, S.A (GRFS) Spain $5.748B 0.00
Ionis Pharmaceuticals (IONS) United States $5.325B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.811B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.998B 10.50
Crinetics Pharmaceuticals (CRNX) United States $2.858B 0.00
Hypermarcas (HYPMY) Brazil $2.716B 17.87
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.288B 12.37
NewAmsterdam Pharma (NAMS) Netherlands $1.979B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.809B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.746B 0.00
Indivior (INDV) United States $1.711B 7.26
ARS Pharmaceuticals (SPRY) United States $1.521B 0.00
Dyne Therapeutics (DYN) United States $1.391B 0.00
Guardian Pharmacy Services (GRDN) United States $1.354B 0.00
Evotec AG (EVO) Germany $1.342B 0.00
Ocular Therapeutix (OCUL) United States $1.297B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.079B 21.59
Harrow (HROW) United States $0.998B 0.00
Ardelyx (ARDX) United States $0.964B 0.00
Collegium Pharmaceutical (COLL) United States $0.938B 5.06
Avadel Pharmaceuticals (AVDL) Ireland $0.892B 0.00
Enliven Therapeutics (ELVN) United States $0.870B 0.00
Akebia Therapeutics (AKBA) United States $0.791B 0.00
Cronos Group (CRON) Canada $0.790B 0.00
Xeris Biopharma Holdings (XERS) United States $0.788B 0.00
AleAnna (ANNA) United States $0.603B 0.00
KalVista Pharmaceuticals (KALV) United States $0.591B 0.00
Elite Pharmaceuticals (ELTP) United States $0.576B 0.00
USANA Health Sciences (USNA) United States $0.562B 12.22
Xencor (XNCR) United States $0.551B 0.00
Regulus Therapeutics (RGLS) United States $0.550B 0.00
Bioventus (BVS) United States $0.539B 13.67
Relay Therapeutics (RLAY) United States $0.528B 0.00
Zevra Therapeutics (ZVRA) United States $0.471B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.465B 0.00
Altimmune (ALT) United States $0.455B 0.00
Oruka Therapeutics (ORKA) United States $0.444B 0.00
Siga Technologies (SIGA) United States $0.440B 9.19
Amylyx Pharmaceuticals (AMLX) United States $0.437B 0.00
CytoDyn (CYDY) United States $0.435B 0.00
Tourmaline Bio (TRML) United States $0.424B 0.00
Verve Therapeutics (VERV) United States $0.410B 0.00
Savara (SVRA) United States $0.387B 0.00
Organogenesis (ORGO) United States $0.362B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.349B 9.43
Tonix Pharmaceuticals Holding (TNXP) United States $0.308B 0.00
Heron Therapeutics (HRTX) United States $0.291B 0.00
Nature's Sunshine Products (NATR) United States $0.281B 25.92
Aquestive Therapeutics (AQST) United States $0.277B 0.00
MediWound (MDWD) Israel $0.231B 0.00
ProKidney (PROK) United States $0.211B 0.00
Nanobiotix S.A (NBTX) France $0.195B 0.00
Journey Medical (DERM) United States $0.188B 0.00
Esperion Therapeutics (ESPR) United States $0.173B 0.00
4D Molecular Therapeutics (FDMT) United States $0.172B 0.00
Wellgistics Health (WGRX) United States $0.167B 0.00
Profound Medical (PROF) Canada $0.160B 0.00
Aclaris Therapeutics (ACRS) United States $0.158B 0.00
Inhibikase Therapeutics (IKT) United States $0.155B 0.00
OmniAb (OABI) United States $0.153B 0.00
Avita Medical (RCEL) United States $0.153B 0.00
Larimar Therapeutics (LRMR) United States $0.147B 0.00
Nektar Therapeutics (NKTR) United States $0.138B 0.00
Aldeyra Therapeutics (ALDX) United States $0.137B 0.00
Liminatus Pharma (LIMN) $0.136B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.132B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Protara Therapeutics (TARA) United States $0.121B 0.00
Lyell Immunopharma (LYEL) United States $0.119B 0.00
Achieve Life Sciences (ACHV) Canada $0.116B 0.00
Korro Bio (KRRO) United States $0.110B 0.00
VAXART, INC (VXRT) United States $0.107B 0.00
Cardiol Therapeutics (CRDL) Canada $0.103B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.102B 0.00
Cassava Sciences (SAVA) United States $0.099B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Inotiv (NOTV) United States $0.096B 0.00
Lexeo Therapeutics (LXEO) United States $0.095B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.093B 0.00
Fractyl Health (GUTS) United States $0.093B 0.00
Arch Biopartners (ACHFF) Canada $0.087B 0.00
Champions Oncology (CSBR) United States $0.085B 14.05
Galectin Therapeutics (GALT) United States $0.078B 0.00
Pyxis Oncology (PYXS) United States $0.077B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.075B 55.89
ESSA Pharma (EPIX) Canada $0.074B 0.00
Surrozen (SRZN) United States $0.073B 0.00
Nutriband (NTRB) United States $0.072B 0.00
Vivani Medical (VANI) United States $0.071B 0.00
Unicycive Therapeutics (UNCY) United States $0.071B 0.00
Dominari Holdings (DOMH) United States $0.067B 0.00
Metagenomi (MGX) United States $0.067B 0.00
Assertio Holdings (ASRT) United States $0.065B 0.00
Telomir Pharmaceuticals (TELO) United States $0.063B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Context Therapeutics (CNTX) United States $0.055B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Prelude Therapeutics (PRLD) United States $0.051B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.050B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
PMV Pharmaceuticals (PMVP) United States $0.047B 0.00
NRx Pharmaceuticals (NRXP) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.046B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.042B 0.00
Avalo Therapeutics (AVTX) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.036B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
Acrivon Therapeutics (ACRV) United States $0.034B 0.00
FibroGen (FGEN) United States $0.032B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
Jupiter Neurosciences (JUNS) United States $0.028B 0.00
Relmada Therapeutics (RLMD) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
China SXT Pharmaceuticals (SXTC) China $0.023B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
DURECT (DRRX) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
MEI Pharma (MEIP) United States $0.015B 0.00
SHINECO (SISI) China $0.015B 0.00
Ainos (AIMD) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
GlycoMimetics (GLYC) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
Mangoceuticals (MGRX) United States $0.013B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.010B 1.83
Talphera (TLPH) United States $0.010B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Aditxt (ADTX) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00